Ping An Biomedical Co., Ltd., provides supply chain management services in the apparel industry in China.
| Revenue (TTM) | $34.15M |
| Gross Profit (TTM) | 949,500 |
| EBITDA | $-14.70M |
| Operating Margin | -69.60% |
| Return on Equity | -67.40% |
| Return on Assets | -14.70% |
| Revenue/Share (TTM) | $1.85 |
| Book Value | $0.33 |
| Price-to-Book | 2.21 |
| Price-to-Sales (TTM) | 0.45 |
| EV/Revenue | 3.197 |
| EV/EBITDA | 423.87 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -62.00% |
| Shares Outstanding | $124.55M |
| Float | $19.22M |
| % Insiders | 55.45% |
| % Institutions | 0.99% |
HONG KONG, July 22, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (hereinafter referred to as “Ping An Biomedical”) announced that it has formally signed a strategic cooperation agreement with Yuan Sheng Mei Yan Health Services (Hainan) Co., Ltd.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PASW and any ticker you trade — then tracks every position and per-strategy win rate.
